Biotechnology Acquisitions in South Dakota
-
- Buyer
- Big Cypress Acquisition Corp., SAB Biotherapeutics, Inc.
- Target
- SAB Biotherapeutics, Inc.
- Industry
- Biotechnology
- Location
- South Dakota, United States
- Type
- Buyout
SAB Biotherapeutics entered into a definitive business combination/merger agreement with Big Cypress Acquisition Corp. (a SPAC), with the combined company to operate as SAB Biotherapeutics and be listed on Nasdaq. Big Cypress stockholders approved the deal, and the transaction was expected to close on or about October 22, 2021, subject to customary conditions.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.